Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
14,289,573
-
Share change
-
+437,508
-
Total reported value
-
$97,478,000
-
Put/Call ratio
-
88%
-
Price per share
-
$6.59
-
Number of holders
-
58
-
Value change
-
+$2,225,233
-
Number of buys
-
28
-
Number of sells
-
48
Institutional Holders of AVEO PHARMACEUTICALS INC - COM NEW (AVEO) as of Q2 2021
As of 30 Jun 2021,
AVEO PHARMACEUTICALS INC - COM NEW (AVEO) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,289,573 shares.
The largest 10 holders included
NEA Management Company, LLC, J. Goldman & Co LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Cormorant Asset Management, LP, Opaleye Management Inc., MILLENNIUM MANAGEMENT LLC, BlackRock Inc., GOLDMAN SACHS GROUP INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
58
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.